Clinical Trial Detail

NCT ID NCT02854436
Title An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

prostate cancer

Therapies

Niraparib

Age Groups: senior adult

No variant requirements are available.